Pentadeca Arginate 500mcg capsules

Pentadeca-Arginate 500 mcg Capsules are an oral formulation of an investigational arginine-rich peptide designed for research into tissue repair, cellular signaling, and metabolic support. Pentadeca-Arginate consists of a 15–amino acid sequence enriched with arginine residues, which may influence nitric oxide (NO) production and cellular communication pathways. Arginine plays a key role as a precursor to nitric oxide, a molecule involved in vasodilation, microcirculation, and tissue oxygenation. Peptides rich in arginine have been studied for their potential to support wound healing, angiogenesis, and modulation of inflammatory responses. In capsule form, Pentadeca-Arginate is intended for investigational or experimental use, although oral bioavailability of peptide-based compounds can be limited due to enzymatic degradation in the gastrointestinal tract. A 500 mcg capsule provides a low-dose, convenient format for controlled research applications. However, compared to injectable peptide forms, oral delivery may result in reduced systemic absorption unless specialized delivery technologies are utilized. Research on arginine and nitric oxide pathways: https://pubmed.ncbi.nlm.nih.gov/12384144/ Studies on arginine-rich peptides and cellular effects: https://pubmed.ncbi.nlm.nih.gov/21295017/